Web-Based Telemonitoring and Delivery of Caregiver Support for Patients With Parkinson Disease After Deep Brain Stimulation: Protocol

Background The increasing number of patients, the high costs of management, and the chronic progress of the disease that prevents patients from performing even simple daily activities make Parkinson disease (PD) a complex pathology with a high impact on society. In particular, patients implanted with deep brain stimulation (DBS) electrodes face a highly fragile stabilization period, requiring specific support at home. However, DBS patients are followed usually by untrained personnel (caregivers or family), without specific care pathways and supporting systems. Objective This projects aims to (1) create a reference consensus guideline and a shared requirements set for the homecare and monitoring of DBS patients, (2) define a set of biomarkers that provides alarms to caregivers for continuous home monitoring, and (3) implement an information system architecture allowing communication between health care professionals and caregivers and improving the quality of care for DBS patients. Methods The definitions of the consensus care pathway and of caregiver needs will be obtained by analyzing the current practices for patient follow-up through focus groups and structured interviews involving health care professionals, patients, and caregivers. The results of this analysis will be represented in a formal graphical model of the process of DBS patient care at home. To define the neurophysiological biomarkers to be used to raise alarms during the monitoring process, neurosignals will be acquired from DBS electrodes through a new experimental system that records while DBS is turned ON and transmits signals by radiofrequency. Motor, cognitive, and behavioral protocols will be used to study possible feedback/alarms to be provided by the system. Finally, a set of mobile apps to support the caregiver at home in managing and monitoring the patient will be developed and tested in the community of caregivers that participated in the focus groups. The set of developed apps will be connected to the already existing WebBioBank Web-based platform allowing health care professionals to manage patient electronic health records and neurophysiological signals. New modules in the WebBioBank platform will be implemented to allow integration and data exchange with mobile health apps. Results The results of this project will provide a novel approach to long-term evaluation of patients with chronic, severe conditions in the homecare environment, based on caregiver empowerment and tailored applications developed according to consensus care pathways established by clinicians. Conclusions The creation of a direct communication channel between health care professionals and caregivers can benefit large communities of patients and would represent a scalable experience in integrating data and information coming from a clinical setting to those in home monitoring.

[1]  Piu Chan,et al.  Epidemiology of Parkinson's disease , 2016 .

[2]  Sara Marceglia,et al.  WebBioBank: A new platform for integrating clinical forms and shared neurosignal analyses to support multi-centre studies in Parkinson's Disease , 2014, J. Biomed. Informatics.

[3]  P. Brown,et al.  The functional role of beta oscillations in Parkinson's disease. , 2014, Parkinsonism & related disorders.

[4]  A. Priori,et al.  Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations , 2013, Experimental Neurology.

[5]  E. Katunina,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[6]  A. Priori,et al.  The Effects of Levodopa and Deep Brain Stimulation on Subthalamic Local Field Low-Frequency Oscillations in Parkinson's Disease , 2012, Neurosignals.

[7]  S. Paek,et al.  The Benefit of Subthalamic Deep Brain Stimulation for Pain in Parkinson Disease: A 2-Year Follow-up Study , 2012, Neurosurgery.

[8]  M. Pang,et al.  Gait Difficulty, Postural Instability, and Muscle Weakness Are Associated with Fear of Falling in People with Parkinson's Disease , 2011, Parkinson's disease.

[9]  Sara Marceglia,et al.  Neurophysiology of deep brain stimulation. , 2012, International review of neurobiology.

[10]  A. Lang,et al.  Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. , 2011, Archives of neurology.

[11]  S. Paek,et al.  Effect of deep brain stimulation on pain in Parkinson disease , 2011, Journal of the Neurological Sciences.

[12]  M. Rizzone,et al.  Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[13]  W. Oertel,et al.  Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. , 2011, Parkinsonism & related disorders.

[14]  Claudio Lucchiari,et al.  Conflict-dependent dynamic of subthalamic nucleus oscillations during moral decisions , 2011, Social neuroscience.

[15]  S. Rehncrona,et al.  Fear of falling and falls in people with Parkinson’s disease treated with deep brain stimulation in the subthalamic nuclei , 2011, Acta neurologica Scandinavica.

[16]  Shyamal Patel,et al.  A Web-Based System for Home Monitoring of Patients With Parkinson's Disease Using Wearable Sensors , 2011, IEEE Transactions on Biomedical Engineering.

[17]  F. Horak,et al.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. , 2011, Archives of neurology.

[18]  Sara Marceglia,et al.  What neurophysiological recordings tell us about cognitive and behavioral functions of the human subthalamic nucleus , 2011, Expert review of neurotherapeutics.

[19]  Chris D. Nugent,et al.  Home-Based Monitoring and Assessment of Parkinson's Disease , 2011, IEEE Transactions on Information Technology in Biomedicine.

[20]  Angie A. Kehagia,et al.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.

[21]  Sara Marceglia,et al.  The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease , 2010, Experimental Neurology.

[22]  G. Alves,et al.  What predicts mortality in Parkinson disease? , 2010, Neurology.

[23]  Y. Agid,et al.  Perspectives on recent advances in the understanding and treatment of Parkinson’s disease , 2009, European journal of neurology.

[24]  B. George,et al.  Telemedicine for the care of nursing home residents with Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[25]  A. S. Grove,et al.  Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at‐home testing device , 2009, Movement disorders : official journal of the Movement Disorder Society.

[26]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[27]  Annamaria Bianchi,et al.  Basal ganglia local field potentials: applications in the development of new deep brain stimulation devices for movement disorders , 2007, Expert review of medical devices.

[28]  A. Priori,et al.  An electronic device for artefact suppression in human local field potential recordings during deep brain stimulation , 2007, Journal of neural engineering.

[29]  K. Winge,et al.  Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: Effects of deep brain stimulation in the subthalamic nucleus , 2007, Movement disorders : official journal of the Movement Disorder Society.

[30]  Elena Moro,et al.  Subthalamic nucleus stimulation: improvements in outcome with reprogramming. , 2006, Archives of neurology.

[31]  G. Deuschl,et al.  A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.

[32]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[33]  G. Deuschl,et al.  Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes , 2006, Movement disorders : official journal of the Movement Disorder Society.

[34]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[35]  Peter Brown,et al.  Basal ganglia local field potential activity: Character and functional significance in the human , 2005, Clinical Neurophysiology.

[36]  G. Baselli,et al.  Movement‐related frequency modulation of beta oscillatory activity in the human subthalamic nucleus , 2005, The Journal of physiology.

[37]  Ivar Jacobson,et al.  Unified Modeling Language User Guide, The (2nd Edition) (Addison-Wesley Object Technology Series) , 2005 .

[38]  S Cerutti,et al.  Physiological recordings from electrodes implanted in the basal ganglia for deep brain stimulation in Parkinson's disease. the relevance of fast subthalamic rhythms. , 2005, Acta neurochirurgica. Supplement.

[39]  A. Priori,et al.  Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease , 2004, Experimental Neurology.

[40]  S Cerutti,et al.  300-Hz subthalamic oscillations in Parkinson's disease. , 2003, Brain : a journal of neurology.

[41]  R. Walker,et al.  Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[42]  Hans Eriksson,et al.  Business Modeling With UML: Business Patterns at Work , 2000 .

[43]  Ivar Jacobson,et al.  The Unified Modeling Language User Guide , 1998, J. Database Manag..

[44]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[45]  A. Benabid,et al.  Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation , 1995, The Lancet.